This is the revamping of the new INREBIC website for the global biopharmaceutical company, Bristol Myers Squibb. INREBIC is a one of the company’s prescription medicines used to treat adults with certain types of myelofibrosis (MF). The task was to implement a friendlier and more consumer-centric representation of the brand for its mobile platform. Responsible for concept, creative direction and design of the project, which included mood boards, style guide, new typography for headlines and body copy, an updated photo library, and development of front-end design of the desktop and mobile pages (while using Figma and InVision) as well as collaboration and direct art direction of UX designers and web developers. The result was more of what the client envisioned, and it now aligns with the company’s mission to upgrade many of its brands’ digital platforms.